S&P 500   3,933.92
DOW   33,597.92
QQQ   280.53
How To Be Persuasive With Your Body Language
"The Bull Market Is Officially OVER"  (Ad)pixel
How to Play Apple and Amazon Heading in 2023
Low Beta, High Yield Campbell Soup Company Is Mmm Mmm Good
"The Bull Market Is Officially OVER"  (Ad)pixel
Microsoft strikes 10-year deal with Nintendo on Call of Duty
Could trawler cams help save world's dwindling fish stocks?
The single greatest medical breakthrough of all time? (Ad)
Southwest Airlines brings back dividend as travel rebounds
Closing prices for crude oil, gold and other commodities
S&P 500   3,933.92
DOW   33,597.92
QQQ   280.53
How To Be Persuasive With Your Body Language
"The Bull Market Is Officially OVER"  (Ad)pixel
How to Play Apple and Amazon Heading in 2023
Low Beta, High Yield Campbell Soup Company Is Mmm Mmm Good
"The Bull Market Is Officially OVER"  (Ad)pixel
Microsoft strikes 10-year deal with Nintendo on Call of Duty
Could trawler cams help save world's dwindling fish stocks?
The single greatest medical breakthrough of all time? (Ad)
Southwest Airlines brings back dividend as travel rebounds
Closing prices for crude oil, gold and other commodities
S&P 500   3,933.92
DOW   33,597.92
QQQ   280.53
How To Be Persuasive With Your Body Language
"The Bull Market Is Officially OVER"  (Ad)pixel
How to Play Apple and Amazon Heading in 2023
Low Beta, High Yield Campbell Soup Company Is Mmm Mmm Good
"The Bull Market Is Officially OVER"  (Ad)pixel
Microsoft strikes 10-year deal with Nintendo on Call of Duty
Could trawler cams help save world's dwindling fish stocks?
The single greatest medical breakthrough of all time? (Ad)
Southwest Airlines brings back dividend as travel rebounds
Closing prices for crude oil, gold and other commodities
S&P 500   3,933.92
DOW   33,597.92
QQQ   280.53
How To Be Persuasive With Your Body Language
"The Bull Market Is Officially OVER"  (Ad)pixel
How to Play Apple and Amazon Heading in 2023
Low Beta, High Yield Campbell Soup Company Is Mmm Mmm Good
"The Bull Market Is Officially OVER"  (Ad)pixel
Microsoft strikes 10-year deal with Nintendo on Call of Duty
Could trawler cams help save world's dwindling fish stocks?
The single greatest medical breakthrough of all time? (Ad)
Southwest Airlines brings back dividend as travel rebounds
Closing prices for crude oil, gold and other commodities
NYSE:PRGO

Perrigo - PRGO Stock Forecast, Price & News

$31.61
-0.12 (-0.38%)
(As of 12/7/2022 12:00 AM ET)
Add
Compare
Today's Range
$31.48
$31.85
50-Day Range
$31.73
$41.31
52-Week Range
$31.01
$43.90
Volume
1.97 million shs
Average Volume
1.42 million shs
Market Capitalization
$4.26 billion
P/E Ratio
N/A
Dividend Yield
3.28%
Price Target
$47.33

Perrigo MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
49.7% Upside
$47.33 Price Target
Short Interest
Healthy
3.42% of Shares Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-1.93
Upright™ Environmental Score
News Sentiment
0.64mentions of Perrigo in the last 14 days
Based on 4 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
38.61%
From $2.02 to $2.80 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.96 out of 5 stars

Medical Sector

24th out of 1,027 stocks

Pharmaceutical Preparations Industry

10th out of 503 stocks

PRGO stock logo

About Perrigo (NYSE:PRGO) Stock

Perrigo Company plc provides over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to prevent or treat conditions that can be self-managed. The company operates through two segments, Consumer Self-Care Americas and Consumer Self-Care International. The Consumer Self-Care Americas segment focuses primarily on the development, manufacture, marketing, and sale of store brand, self-care products in categories, including upper respiratory, pain and sleep-aids, digestive health, nutrition, vitamins, minerals and supplements, healthy lifestyle, skincare and personal hygiene, and oral self-care in the United States, Mexico, Canada, and South America. The segment offers its products under the Prevacid 24HR, Good Sense, Zephrex D, ScarAway, Plackers, Rembrandt, Steripod, Firefly, REACH, Dr. Fresh, and Burt's Bees brand names. The Consumer Self-Care International segment develops, manufactures, markets, and distributes consumer self-care brands through a network of pharmacies, wholesalers, drug and grocery store retailers, and para-pharmacies in approximately 23 countries, primarily in Europe. The company also offers contract manufacturing services. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

Receive PRGO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Perrigo and its competitors with MarketBeat's FREE daily newsletter.

PRGO Stock News Headlines

Perrigo (NYSE:PRGO) Sets New 52-Week Low at $31.31
Perrigo Company plc (NYSE:PRGO) Declares $0.26 Quarterly Dividend
Why Perrigo Stock Tanked on Tuesday
Perrigo (PRGO) Earnings Expected to Grow: Should You Buy?
Perrigo Company plc (PRGO)
Perrigo: Back On Track (NYSE:PRGO) - Seeking Alpha
See More Headlines
Receive PRGO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Perrigo and its competitors with MarketBeat's FREE daily newsletter.

PRGO Company Calendar

Ex-Dividend for 9/20 Dividend
9/01/2022
Dividend Payable
9/20/2022
Last Earnings
11/08/2022
Ex-Dividend for 12/20 Dividend
12/01/2022
Today
12/08/2022
Dividend Payable
12/20/2022
Fiscal Year End
12/31/2022
Next Earnings (Estimated)
3/07/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceuticals
Sector
Medical
CUSIP
71429010
Employees
9,900
Year Founded
1887

Price Target and Rating

Average Stock Price Forecast
$47.33
High Stock Price Forecast
$54.00
Low Stock Price Forecast
$42.00
Forecasted Upside/Downside
+49.7%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

Net Income
$-68,900,000.00
Pretax Margin
-2.61%

Debt

Sales & Book Value

Annual Sales
$4.14 billion
Cash Flow
$4.35 per share
Book Value
$38.51 per share

Miscellaneous

Free Float
133,563,000
Market Cap
$4.26 billion
Optionable
Optionable
Beta
0.84

Social Links


Key Executives

  • Mr. Murray S. Kessler (Age 62)
    CEO, Pres & Director
    Comp: $2.78M
  • Mr. Svend  AndersenMr. Svend Andersen (Age 60)
    Exec. VP & Pres of Consumer Self-Care International
    Comp: $1.18M
  • Mr. James E. Dillard III (Age 58)
    Exec. VP & Pres of Consumer Self-Care Americas
    Comp: $999.36k
  • Mr. Eduardo Guarita Bezerra (Age 47)
    Exec. VP & CFO
  • Mr. Ronald C. JanishMr. Ronald C. Janish (Age 56)
    Chief Transformation Officer and Exec. VP of Global Operations & Supply Chain
  • Mr. Shannon Hukill
    Sr. Director of Technical Operations
  • Mr. Thomas M. FarringtonMr. Thomas M. Farrington (Age 65)
    Chief Information Officer & Exec. VP
  • Ms. Alison Ives
    Exec. VP & Chief Scientific Officer
  • Mr. Bradley Joseph
    VP of Global Investor Relations & Corp. Communications
  • Ms. Kyle L. Hanson (Age 57)
    Exec. VP, Gen. Counsel & Corp. Sec.













PRGO Stock - Frequently Asked Questions

Should I buy or sell Perrigo stock right now?

3 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Perrigo in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" PRGO shares.
View PRGO analyst ratings
or view top-rated stocks.

What is Perrigo's stock price forecast for 2023?

3 equities research analysts have issued 1 year price objectives for Perrigo's stock. Their PRGO share price forecasts range from $42.00 to $54.00. On average, they predict the company's share price to reach $47.33 in the next twelve months. This suggests a possible upside of 49.7% from the stock's current price.
View analysts price targets for PRGO
or view top-rated stocks among Wall Street analysts.

How have PRGO shares performed in 2022?

Perrigo's stock was trading at $38.90 at the beginning of 2022. Since then, PRGO shares have decreased by 18.7% and is now trading at $31.61.
View the best growth stocks for 2022 here
.

Are investors shorting Perrigo?

Perrigo saw a increase in short interest in the month of November. As of November 15th, there was short interest totaling 4,610,000 shares, an increase of 17.3% from the October 31st total of 3,930,000 shares. Based on an average daily volume of 1,310,000 shares, the days-to-cover ratio is currently 3.5 days.
View Perrigo's Short Interest
.

When is Perrigo's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, March 7th 2023.
View our PRGO earnings forecast
.

How were Perrigo's earnings last quarter?

Perrigo Company plc (NYSE:PRGO) issued its quarterly earnings results on Tuesday, November, 8th. The company reported $0.56 earnings per share for the quarter, missing analysts' consensus estimates of $0.66 by $0.10. The company earned $1.10 billion during the quarter, compared to analyst estimates of $1.14 billion. Perrigo had a positive trailing twelve-month return on equity of 5.31% and a negative net margin of 1.93%. Perrigo's revenue was up 5.5% on a year-over-year basis. During the same quarter last year, the business earned $0.45 EPS.
Read the conference call transcript
.

How often does Perrigo pay dividends? What is the dividend yield for Perrigo?

Perrigo declared a quarterly dividend on Thursday, November 3rd. Shareholders of record on Friday, December 2nd will be given a dividend of $0.26 per share on Tuesday, December 20th. This represents a $1.04 dividend on an annualized basis and a yield of 3.29%. The ex-dividend date is Thursday, December 1st.
Read our dividend analysis for PRGO
.

Is Perrigo a good dividend stock?

Perrigo (NYSE:PRGO) pays an annual dividend of $1.04 per share and currently has a dividend yield of 3.28%.
Read our dividend analysis for PRGO.

What guidance has Perrigo issued on next quarter's earnings?

Perrigo issued an update on its FY 2022 earnings guidance on Tuesday, November, 8th. The company provided earnings per share (EPS) guidance of $2.00-$2.10 for the period, compared to the consensus estimate of $2.28. The company issued revenue guidance of $4.49 billion-$4.53 billion, compared to the consensus revenue estimate of $4.53 billion.

What is Murray S. Kessler's approval rating as Perrigo's CEO?

38 employees have rated Perrigo Chief Executive Officer Murray S. Kessler on Glassdoor.com. Murray S. Kessler has an approval rating of 83% among the company's employees.

What other stocks do shareholders of Perrigo own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Perrigo investors own include Teva Pharmaceutical Industries (TEVA), Gilead Sciences (GILD), Mylan (MYL), AbbVie (ABBV), Allergan (AGN), Intel (INTC), Johnson & Johnson (JNJ), Netflix (NFLX), QUALCOMM (QCOM) and Amgen (AMGN).

What is Perrigo's stock symbol?

Perrigo trades on the New York Stock Exchange (NYSE) under the ticker symbol "PRGO."

Who are Perrigo's major shareholders?

Perrigo's stock is owned by many different institutional and retail investors. Top institutional investors include Vanguard Group Inc. (10.64%), BlackRock Inc. (9.32%), Barrow Hanley Mewhinney & Strauss LLC (7.70%), Dimensional Fund Advisors LP (4.26%), State Street Corp (3.12%) and Coho Partners Ltd. (2.77%). Insiders that own company stock include Bradley A Alford, Geoffrey M Parker, Raymond Silcock, Richard S Sorota, Rolf A Classon, Ronald Craig Janish, Svend Andersen, Theodore R Samuels II, Thomas Farrington and Todd W Kingma.
View institutional ownership trends
.

How do I buy shares of Perrigo?

Shares of PRGO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Perrigo's stock price today?

One share of PRGO stock can currently be purchased for approximately $31.61.

How much money does Perrigo make?

Perrigo (NYSE:PRGO) has a market capitalization of $4.26 billion and generates $4.14 billion in revenue each year. The company earns $-68,900,000.00 in net income (profit) each year or ($0.63) on an earnings per share basis.

How many employees does Perrigo have?

The company employs 9,900 workers across the globe.

Does Perrigo have any subsidiaries?
The following companies are subsidiares of Perrigo: 010414 UK Limited, 251211 UK Limited, Abtei Omega Pharma GmbH, Aco Hud Nordic AB, Adriatic BST Trgovina in Storitve D.o.o., Adriatic Distribution doo Beograd, Agis Industries, Algorithmics Risk Management Limited, Arginet Investments and Property (2003) Ltd., Athena Neurosciences LLC, Aurora Pharmaceuticals Pty Ltd, Biover NV, Blue Wolf Global Limited, Bluewolf International Limited, Brunel Healthcare Manufacturing Limited, CP Kayak Holdings Inc., CanNegev Ltd, Chefaro Ireland Designated Activity Company, Cinetic Laboratories Argentina SA, Cleversafe UK Limited, Cosmediet - Biotechnie SAS, Despharma Kft., Elan Corporation, Elan Europa Finance S.á r.l., Elan International Services Limited, Elan Pharmaceuticals LLC, Fera Pharmaceuticals, Galpharm Healthcare Limited, Galpharm International, Galpharm International Limited, Geiss Destin & Dunn, Gelcaps Exportadora de Mexico S.A. de C.V., Gr8ness LLC, HRA Pharma, Habsont Unlimited Company, Heartbeat Experts Limited, IBM GF international Treasury Company, IBM International Treasury Services Unlimited Company, IBM Netherlands Treasury B.V., Interdelta S.A., International Business Machines Limited, Irish Biosciences Venture Capital Fund, JB Laboratories, JLR Pharma S.A., Jaico R.D.P. NV, Jewel Consumer Care Pvt. Ltd., Kazmira LLC, Kenexa Global Recruitment Services Limited, Kenexa Quorum Holdings Limited, Kenexa Technology LLC, Kiteacre Limited, L. Perrigo Company, Laboratoire de la Mer SAS, Laboratoires Omega Pharma France SAS, Laboratorios DIBA S.A., Laboratorios Diba, Luxembourg Investment Company 289 Sàrl, MH (UK) Limited, Medgenix Benelux NV, Monksland Holdings B.V., Naturwohl Pharma GmbH, ORION Laboratories, Oce Bio BV, Oce-Bio Nederland B.V., Omega Alpharm Cyprus Ltd., Omega Pharma, Omega Pharma AS, Omega Pharma Australia Pty Ltd, Omega Pharma Austria Healthcare GmbH, Omega Pharma Baltics SIA, Omega Pharma Belgium NV, Omega Pharma Capital NV, Omega Pharma Deutschland GmbH, Omega Pharma GmbH, Omega Pharma Hellas SA Health and Beauty Products, Omega Pharma Hungary Kft., Omega Pharma Innovation & Development NV, Omega Pharma International NV, Omega Pharma Limited, Omega Pharma Luxembourg SarL, Omega Pharma Manufacturing GmbH & Co. KG, Omega Pharma Manufacturing Verwaltungs GmbH, Omega Pharma Nederland B.V., Omega Pharma Trading NV, Omega Pharma s.r.o., Omega Teknika Designated Activity Company, OmegaLabs (Pty) Ltd, Oniqua Europe Limited, Optevia Limited, Orion Laboratories (NZ) Ltd., Orion Laboratories PTY Limited, P-Direct NL B.V., P2C Inc., PBM Canada Holdings LLC, PBM China Holdings LLC, PBM Foods LLC, PBM Holdings LLC, PBM International Holdings LLC, PBM Mexico Holdings LLC, PBM Nutritionals LLC, PBM Products, PBM Products LLC, PBM Products Mexico S de R.L. de C.V., PMI Branded Pharmaceuticals Inc., Paddock Laboratories, Paracelsia Pharma GmbH, Perrigo Asia Holding Company Ltd., Perrigo Australian Holding Company II PTY Limited, Perrigo Bulgaria OOD, Perrigo China Business Trust, Perrigo China Business Trustee LLC, Perrigo Company, Perrigo Company Charitable Foundation, Perrigo Company of Tennessee, Perrigo Company plc, Perrigo Corporation Designated Activity Company, Perrigo Danmark A/S, Perrigo Diabetes Care LLC, Perrigo Direct Inc., Perrigo España SA, Perrigo Europe Invest NV, Perrigo Finance (US) LLC, Perrigo Finance Unlimited Company, Perrigo Florida Inc., Perrigo France SAS, Perrigo Global Holdings Inc., Perrigo Holding NV, Perrigo Holdings Unlimited Company, Perrigo International Finance Designated Activity Company, Perrigo International Holdings II Inc., Perrigo International Holdings LLC, Perrigo International Inc., Perrigo International Insurance Limited, Perrigo Ireland 1 Designated Activity Company, Perrigo Ireland 10 Unlimited Company, Perrigo Ireland 11 DAC, Perrigo Ireland 12 Designated Activity Company, Perrigo Ireland 13 Designated Activity Company, Perrigo Ireland 2 Designated Activity Company, Perrigo Ireland 3 Designated Activity Company, Perrigo Ireland 4 Unlimited Company, Perrigo Ireland 5 Unlimited Company, Perrigo Ireland 6 Unlimited Company, Perrigo Ireland 7 Designated Activity Company, Perrigo Ireland 8 Designated Activity Company, Perrigo Ireland 9 Unlimited Company, Perrigo Ireland Holding Company B.V., Perrigo Ireland Management Designated Activity Company, Perrigo Israel Enterprises & Investments Ltd., Perrigo Israel Holdings II B.V., Perrigo Israel Opportunities II Ltd., Perrigo Israel Trading Limited Partnership, Perrigo Italia S.r.l, Perrigo Kişisel Bakım Ürünleri Sanayi ve Ticaret Limited Şirketi, Perrigo LLC, Perrigo Laboratories India Private Limited, Perrigo Management Company, Perrigo Mexico Holding S.A. de C.V., Perrigo Mexico Investment Holdings LLC, Perrigo Netherlands B.V., Perrigo Netherlands Finco 1 Coöperatief U.A., Perrigo Netherlands Finco 2 B.V., Perrigo Netherlands International Partnership C.V., Perrigo New York Inc., Perrigo Norge AS, Perrigo Oral Health Care Holdings Inc., Perrigo Pharma Holding Nederland BV, Perrigo Pharma International Designated Activity Company, Perrigo Pharma Limited, Perrigo Poland Sp.z.o.o, Perrigo Portugal LDA, Perrigo Research & Development Company, Perrigo România S.R.L., Perrigo Sales Corporation, Perrigo Science Eight Unlimited Company, Perrigo Science One Designated Activity Company, Perrigo Suomi Oy, Perrigo Sverige AB, Perrigo Trading (Shanghai) Co. Ltd., Perrigo UK Acquisition Limited, Perrigo UK Finco Limited Partnership, Perrigo Ukraine LLC, Perrigo Ventures Limited Partnership, Perrigo de Mexico S.A. de C.V., Perrigo do Brasil Farmaceutica Ltda., Pharma Clal (1983) Ltd., Promontory Financial Group (UK) Limited, Quimica y Farmacia S.A. de C.V., Ranir, Ranir (Holdings) Limited, Ranir Changshu Oral Care CO. Ltd., Ranir Global Holdings LLC, Ranir LLC, Ranir Limited, Resilient Systems Europe Limited, Richard Bittner AG, Rosemont Pharmaceuticals, Rubicon Healthcare Holdings Pty Ltd, SPSS Limited, Samenwerkende Apothekers Nederland B.V., ScarAway, Silverpop Systems Limited, Simpler Consulting Limited, Solent Dental Company Limited, Solent Oral Care Limited, Sterling Commerce (UK) Limited, The Analytic Sciences Corporation Limited, The Learning Pharmacy Limited, The Weather Channel Global Media Limited, Totalcare International Corp, Transitive Corporation Limited, Transitive Limited, Truven Health Analytics UK Limited, Velcera, Weather Services International Limited, Wrafton Laboratories, Wrafton Laboratories Limited, Zibo Xinhua - Perrigo Pharmaceutical Company Ltd., i2 Holdings Limited, i2 Intermediate Holdings Limited, and i2 Limited.
Read More
How can I contact Perrigo?

Perrigo's mailing address is THE SHARP BUILDING HOGAN PLACE, DUBLIN L2, 49010. The official website for the company is www.perrigo.com. The company can be reached via phone at (531) 709-4000, via email at bradley.joseph@perrigo.com, or via fax at 269-673-9128.

This page (NYSE:PRGO) was last updated on 12/8/2022 by MarketBeat.com Staff